CARLSBAD, Calif. and BOSTON, Aug. 9, 2016 /PRNewswire/ -- Industry thought leaders are gearing up for BioPharm America™ with in-depth content pieces that focus on core innovation areas on the program at BioPharm America (#BioPharmAmerica) life science partnering event taking place in Boston September 13–15.
John Carroll, Editor and Co-founder of Endpoints and a long-time journalist in the life sciences, has written two articles in a six-part series that gives insight on hot biotech companies to watch. The series, including the first two articles, "Companies to watch: Biotech startups get trendy," and "At a crossroads, Ironwood CEO Peter Hecht maps a big leap forward," can be found on EBD Group's Insight. The series coincides with Biotech Startup Day (#BPAStartupDay), a one-day event featuring interactive roundtable discussions among pharma executives, finance experts and entrepreneurs, and pitches by a curated group of Boston-area startups.
Luke Timmerman has just published an in-depth article on "12 serial entrepreneurs who've created value in biotech over, and over, again."Katrine Bosley, CEO of Editas Medicine; Tillman Gerngross, Professor of Bioengineering at the Thayer School of Engineering at Dartmouth College; Craig Venter, Founder, Chairman, and CEO of the J. Craig Venter Institute (JCVI); and Troy Wilson, President and Chief Executive Officer of Kura Oncology, Inc., are just a few of those included. "Biotech is absolutely a team sport," Wilson said in the article. "The thing I have a skill for is recruiting great people, helping them set ambitious goals, and challenging them to meet or exceed those goals." The biotech entrepreneurs mentioned in the piece will be featured in a panel at BioPharm America called, "What makes a serial entrepreneur tick and why are they so successful?"
A white paper on the convergence of new technologies, medications, therapies, digital fields and the health ecosystem commissioned by EBD Group will be published in August and will give an overview of the innovations and challenges faced by digital medicine companies. According to the paper, digital tools and devices "are already turning personal and clinical data, whether quantitative or qualitative, into entirely new breeds of medical information, and altering business models across industries." The paper, entitled "The digital medicine crystal ball: Unlocking the future of real-time, precise, effective healthcare," includes interviews with key stakeholders in the field, many of whom will be participating in the Digital Medicine Connect (#DigitalMedicineConnect) program at BioPharm America.
In addition, an exclusive white paper being developed in collaboration with Scrip Intelligence, Informa Pharma Intelligence and Datamonitor entitled "Pursuing excellence: Identifying the industry's top performers" will be released during BioPharm America. This report identifies the top performing pharma companies and products across a number of key metrics, and which drugs are not only the best selling, but also those which are fast growing and will likely be top of the pile in the coming years.
BioPharm America will be held at the Boston Marriott Copley Place in the heart of Boston. Produced by EBD Group in collaboration with the Massachusetts Biotechnology Council (MassBio), the event features presentations from cutting edge biotech companies and early stage startups, and is attended annually by hundreds of executives from global pharmaceutical companies, investors and service companies in search of partners.
Additional links and information:
Follow BioPharm America 2016 on Twitter: @EBDGroup (hashtag: #BioPharmAmerica).
Online Press Kit service for BioPharm America™ 2016 is available from Virtual Press Office/PR Newswire to enhance your public relations efforts.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group's conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® andBIO-Europe Spring®, Europe's largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® Group
- Biolatam®, facilitating partnering among global life sciences executives in Latin America's vibrant life science hubs
EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/partnering-strategy-and-thought-leadership-in-biotech-startups-serial-entrepreneurship-and-digital-medicine-are-themes-of-biopharm-america-2016-300311135.html
SOURCE EBD Group